Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Sell
35
LFWD Quote, Financials, Valuation and Earnings
Last price:
$0.65
Seasonality move
:
-8.21%
Day range:
$0.67 - $0.71
52-week range:
$0.50 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.32x
P/B ratio:
0.93x
Volume:
256.6K
Avg. volume:
366.8K
1-year change:
-57.29%
Market cap:
$11.9M
Revenue:
$25.7M
EPS (TTM):
-$2.98
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
|
$7.9M | -$0.09 | 4.27% | -94.81% | $7.25 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -57.02% | -40.33% | $12.3077 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
TWST
Twist Bioscience Corp.
|
$101.5M | -$0.52 | 12.47% | -2.62% | $40.50 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 227.21% | -28.83% | $2.20 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
|
$0.67 | $7.25 | $11.9M | -- | $0.00 | 0% | 0.32x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.7100 | $12.3077 | $201.5M | -- | $0.00 | 0% | 183.75x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.48 | $14.20 | $172.5M | 32.43x | $0.00 | 0% | 1.28x |
|
TWST
Twist Bioscience Corp.
|
$42.94 | $40.50 | $2.6B | -- | $0.00 | 0% | 6.85x |
|
VNRX
VolitionRX Ltd.
|
$0.28 | $2.20 | $34.6M | -- | $0.00 | 0% | 19.32x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.65 | $1.50 | $91.4M | 64.00x | $0.00 | 0% | 0.71x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
|
1.82% | -2.286 | 1.98% | 0.94x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
TWST
Twist Bioscience Corp.
|
13.78% | 0.672 | 4.43% | 3.17x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
|
$2.7M | -$3.1M | -146.07% | -150.63% | -50.69% | -$3.8M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
TWST
Twist Bioscience Corp.
|
$50.8M | -$29.9M | -14.27% | -16.74% | -30.24% | -$24.2M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Lifeward Ltd. vs. Competitors
-
Which has Higher Returns LFWD or CATX?
Perspective Therapeutics, Inc. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -12425.36%. Lifeward Ltd.'s return on equity of -150.63% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital LFWDLifeward Ltd.43.7% -$0.20 $13M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About LFWD or CATX?
Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 981.12%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 354.16%. Given that Lifeward Ltd. has higher upside potential than Perspective Therapeutics, Inc., analysts believe Lifeward Ltd. is more attractive than Perspective Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFWDLifeward Ltd.1 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is LFWD or CATX More Risky?
Lifeward Ltd. has a beta of 0.002, which suggesting that the stock is 99.817% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock LFWD or CATX?
Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFWD or CATX?
Lifeward Ltd. quarterly revenues are $6.2M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Lifeward Ltd.'s net income of -$3.2M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.32x versus 183.75x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFWDLifeward Ltd.0.32x -- $6.2M -$3.2M CATXPerspective Therapeutics, Inc.183.75x -- $209K -$26M
-
Which has Higher Returns LFWD or INFU?
InfuSystem Holdings, Inc. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of 6.19%. Lifeward Ltd.'s return on equity of -150.63% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital LFWDLifeward Ltd.43.7% -$0.20 $13M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About LFWD or INFU?
Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 981.12%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 67.45%. Given that Lifeward Ltd. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Lifeward Ltd. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFWDLifeward Ltd.1 0 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is LFWD or INFU More Risky?
Lifeward Ltd. has a beta of 0.002, which suggesting that the stock is 99.817% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock LFWD or INFU?
Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFWD or INFU?
Lifeward Ltd. quarterly revenues are $6.2M, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Lifeward Ltd.'s net income of -$3.2M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 32.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.32x versus 1.28x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFWDLifeward Ltd.0.32x -- $6.2M -$3.2M INFUInfuSystem Holdings, Inc.1.28x 32.43x $36.5M $2.3M
-
Which has Higher Returns LFWD or TWST?
Twist Bioscience Corp. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -27.41%. Lifeward Ltd.'s return on equity of -150.63% beat Twist Bioscience Corp.'s return on equity of -16.74%.
Company Gross Margin Earnings Per Share Invested Capital LFWDLifeward Ltd.43.7% -$0.20 $13M TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M -
What do Analysts Say About LFWD or TWST?
Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 981.12%. On the other hand Twist Bioscience Corp. has an analysts' consensus of $40.50 which suggests that it could fall by -5.68%. Given that Lifeward Ltd. has higher upside potential than Twist Bioscience Corp., analysts believe Lifeward Ltd. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings LFWDLifeward Ltd.1 0 0 TWSTTwist Bioscience Corp.7 2 0 -
Is LFWD or TWST More Risky?
Lifeward Ltd. has a beta of 0.002, which suggesting that the stock is 99.817% less volatile than S&P 500. In comparison Twist Bioscience Corp. has a beta of 2.191, suggesting its more volatile than the S&P 500 by 119.099%.
-
Which is a Better Dividend Stock LFWD or TWST?
Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Twist Bioscience Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Twist Bioscience Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFWD or TWST?
Lifeward Ltd. quarterly revenues are $6.2M, which are smaller than Twist Bioscience Corp. quarterly revenues of $99M. Lifeward Ltd.'s net income of -$3.2M is higher than Twist Bioscience Corp.'s net income of -$27.1M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Twist Bioscience Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.32x versus 6.85x for Twist Bioscience Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFWDLifeward Ltd.0.32x -- $6.2M -$3.2M TWSTTwist Bioscience Corp.6.85x -- $99M -$27.1M
-
Which has Higher Returns LFWD or VNRX?
VolitionRX Ltd. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -862.39%. Lifeward Ltd.'s return on equity of -150.63% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFWDLifeward Ltd.43.7% -$0.20 $13M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About LFWD or VNRX?
Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 981.12%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 680.14%. Given that Lifeward Ltd. has higher upside potential than VolitionRX Ltd., analysts believe Lifeward Ltd. is more attractive than VolitionRX Ltd..
Company Buy Ratings Hold Ratings Sell Ratings LFWDLifeward Ltd.1 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is LFWD or VNRX More Risky?
Lifeward Ltd. has a beta of 0.002, which suggesting that the stock is 99.817% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock LFWD or VNRX?
Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFWD or VNRX?
Lifeward Ltd. quarterly revenues are $6.2M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Lifeward Ltd.'s net income of -$3.2M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.32x versus 19.32x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFWDLifeward Ltd.0.32x -- $6.2M -$3.2M VNRXVolitionRX Ltd.19.32x -- $627.3K -$5.4M
-
Which has Higher Returns LFWD or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of 3.93%. Lifeward Ltd.'s return on equity of -150.63% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital LFWDLifeward Ltd.43.7% -$0.20 $13M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About LFWD or XTNT?
Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 981.12%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 129.78%. Given that Lifeward Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Lifeward Ltd. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFWDLifeward Ltd.1 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is LFWD or XTNT More Risky?
Lifeward Ltd. has a beta of 0.002, which suggesting that the stock is 99.817% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.
-
Which is a Better Dividend Stock LFWD or XTNT?
Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFWD or XTNT?
Lifeward Ltd. quarterly revenues are $6.2M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Lifeward Ltd.'s net income of -$3.2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 64.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.32x versus 0.71x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFWDLifeward Ltd.0.32x -- $6.2M -$3.2M XTNTXtant Medical Holdings, Inc.0.71x 64.00x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
70
BNAI alert for Jan 26
Brand Engagement Network, Inc. [BNAI] is up 279.19% over the past day.
Buy
56
INTC alert for Jan 26
Intel Corp. [INTC] is down 5.77% over the past day.
Buy
64
BNR alert for Jan 26
Burning Rock Biotech Ltd. [BNR] is up 1.45% over the past day.
